Professors

Cheríe Blair, MD, PhD

University of California Los Angeles

Assistant Clinical Professor

Los Angeles, CA

Ole-Petter R. Hamnvik, MBBCH

Brigham and Women's Hospital

Boston, MA

Latesha Elopre, MD

University of Alabama at Birmingham

Associate Professor

Birmingham, AL

Brenda E. Crabtree-Ramirez, MD

Universidad Nacional Autónoma de México (UNAM)

Assistant Professor of the HIV Program

Mexico City, Mexico

Paul C. Adamson, MD, MPH

University of California Los Angeles

Professor of Medicine

Los Angeles, CA

Selvi Rajagopal, MD, MPH

The Johns Hopkins University

Lutherville, MD

Toby Maurer, MD

Indiana University

Professor of Clinical Dermatology

Indianapolis, IN

Daria Van Tyne, PhD

University of Pittsburgh

Assistant Professor of Medicine

Pittsburgh, PA

Dr Van Tyne completed her undergraduate work at Vassar College, followed by PhD studies at the Harvard T.H. Chan School of Public Health. She then pursued postdoctoral training at Harvard Medical School and joined the Division of Infectious Diseases at the University of Pittsburgh School of Medicine as an Assistant Professor in July 2018. The Van Tyne lab studies how bacteria evolve during human infection and develops new approaches for treating antibiotic-resistant infections. She is the Chair of the Phage Biology and Discovery Working Group of the Pittsburgh Phage Project.

(Updated July 18, 2024)

Paul E. Turner, PhD

Yale University

Rachel Carson Professor of Ecology and Evolutionary Biology

New Haven, CT

Dr Turner is the Rachel Carson Professor of Ecology and Evolutionary Biology (EEB) at Yale University and a Microbiology faculty member at Yale School of Medicine. He obtained a BA in Biology (1988) from University of Rochester, a PhD in Microbial Evolution (1995) from Michigan State University, and did postdoctoral fellowships at the National Institutes of Health, University of Valencia in Spain, and University of Maryland-College Park before joining Yale in 2001. Dr Turner previously served as Director of Graduate Studies and Chair of EEB and as Interim Dean of Science. He currently serves as Director of the Center for Phage Biology and Therapy at Yale and also directs Yale’s Quantitative Biology Institute. Dr Turner studies evolutionary genetics of viruses, particularly phages (bacteria-specific viruses) that infect bacterial pathogens and RNA viruses transmitted by mosquitoes, and he researches the use of phages to treat antibiotic-resistant bacterial diseases. He is very active in science-communication outreach to the general public and is involved in the Yale National Initiative, where faculty collaborate with K-12 teachers to improve STEMM education in underserved public schools. Dr Turner’s current service includes the National Science Foundation’s Bio Advisory Committee and President of the International Society for Evolution, Medicine and Public Health. His honors include Fellowships in the National Academy of Sciences, American Academy of Arts & Sciences, and American Academy of Microbiology.

(Updated July 18, 2024)

Gina A. Suh, MD

Mayo Clinic

Assistant Professor

Rochester, MN

Dr Suh is an Infectious Diseases specialist at Mayo Clinic with expertise in the field of Orthopedic Infectious Diseases and phage therapy. Dr Suh created the Musculoskeletal-ID program, a multi-disciplinary program encompassing ID, Orthopedics, Plastics, and Vascular surgery at Stanford University. Dr Suh is the founder and director of Mayo’s Phage Therapy Program and has a special interest in bacteriophages and lysins as novel therapeutics for the treatment of infections, particularly multidrug resistant and biofilm-mediated infections. She treated Mayo’s first phage therapy patients and is heading efforts to run phage-related clinical trials.

(Updated July 18, 2024)